Icrom is a contract manufacturer based in Italy. It holds 11 active US drug master files and 10 valid CEPs across a filed portfolio of 13 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 28 February 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Concorezzo, Italy | Not on file |
| Italy, Italy | 3007410503 |
| Molecule | Regulators | Docs |
|---|---|---|
| Amisulpride | EDQM, US FDA | 3 |
| Fluorescein | EDQM, US FDA | 3 |
| Minoxidil | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Methylene Blue | EDQM, US FDA | 2 |
| Metoclopramide | EDQM, US FDA | 2 |
| Risperidone | EDQM, US FDA | 2 |
| Bepotastine | US FDA | 1 |
| Brinzolamide | US FDA | 1 |
| Diacerein | EDQM | 1 |
| Epinastine | US FDA | 1 |
| Indocyanine Green | US FDA | 1 |
| Sulpiride | EDQM | 1 |
| Tiapride | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 1 | None |
| US FDA | None | 1 |
Choose your molecules and target markets. Icrom comes back tiered against every other supplier able to file there.
Start for free